about
Differences in the Cardiometabolic Control in Type 2 Diabetes according to Gender and the Presence of Cardiovascular Disease: Results from the eControl Study.Chronic kidney disease in the type 2 diabetic patients: prevalence and associated variables in a random sample of 2642 patients of a Mediterranean area.Comparison of different vascular risk engines in the identification of type 2 diabetes patients with high cardiovascular risk.Control of glycemia and cardiovascular risk factors in patients with type 2 diabetes in primary care in Catalonia (Spain).Chronic Kidney Disease and Diabetic Retinopathy in Patients with Type 2 Diabetes.Patient-reported outcomes in type 2 diabetes mellitus: patients' and primary care physicians' perspectives in the Spanish health care systemPrevalence of diabetic retinopathy in individuals with type 2 diabetes who had recorded diabetic retinopathy from retinal photographs in Catalonia (Spain)Noninsulin Antidiabetic Drugs for Patients with Type 2 Diabetes Mellitus: Are We Respecting Their Contraindications?Fifteen years of continuous improvement of quality care of type 2 diabetes mellitus in primary care in Catalonia, SpainAssociation of low oleic acid intake with diabetic retinopathy in type 2 diabetic patients: a case-control study.Cardiometabolic Risk Profiles in Patients With Impaired Fasting Glucose and/or Hemoglobin A1c 5.7% to 6.4%: Evidence for a Gradient According to Diagnostic Criteria: The PREDAPS Study.Direct medical costs attributable to type 2 diabetes mellitus: a population-based study in Catalonia, Spain.Older type 2 diabetic patients are more likely to achieve glycaemic and cardiovascular risk factors targets than younger patients: analysis of a primary care database.Understanding the physical, social, and emotional experiences of people with uncontrolled Type 2 diabetes: a qualitative study.Reference values for TSH may be inadequate to define hypothyroidism in persons with morbid obesity: Di@bet.es study.Is diabetes mellitus correctly registered and classified in primary care? A population-based study in Catalonia, Spain.Prevalence of Diabetic Foot Disease in Patients with Diabetes Mellitus under Renal Replacement Therapy in Lleida, Spain.[The evolution of quality care indicators of patients with type 2 diabetes in the Spanish primary care (1996-2007). The RedGEDAPS quality of care program].Do Patients With High Vascular Risk Take Antihypertensive Medication Correctly? Cumple-MEMS Study.The diabetic immigrant: cardiovascular risk factors and control. Contributions of the IDIME study.Clinical inertia in the treatment of hyperglycemia in type 2 diabetes patients in primary care.Barriers associated with poor control in Spanish diabetic patients. A consensus study.Clinical characteristics of type 2 diabetic patients on basal insulin therapy with adequate fasting glucose control who do not achieve HbA1c targets.[Individualized treatment of diabetic patients in special clinical situations].[Prevalence of metabolic syndrome in the adult population of Yecla (Murcia). Degree of agreement between three definitions of it].Non-compliance and inertia in hypertensive Spaniards at high cardiovascular risk: CUMPLE study.Physicians' and Pharmacists' Clinical Considerations for Elderly Patients with Type 2 Diabetes Mellitus: The IMPLICA2 StudyMetabolic control and cardiovascular risk factors in type 2 diabetes mellitus patients according to diabetes durationSaxagliptin and risk of heart failure hospitalization: Concern or miscalculation?Investigar en diabetes desde una base de datos de atención primaria: la experiencia del Sistema de Información para el Desarrollo de la Investigación en Atención Primaria (SIDIAP)Obesidad intraabdominal y riesgo cardiometabólicoCorrelación entre las diferentes medidas de obesidad y el grado de resistencia a la insulinaConocimiento y aplicación de las guías de práctica clínica sobre riesgo cardiovascular en las consultas generales y especializadasVariabilidad en la estimación del riesgo coronario en la diabetes mellitus tipo 2Dairy Product Consumption and Metabolic Diseases in the Di@bet.es StudyUltrasound Tissue Characterization of Carotid Plaques Differs Between Patients with Type 1 Diabetes and Subjects without Diabetes.The Association Between Poor Glycemic Control and Health Care Costs in People With Diabetes: A Population-Based StudyIncidence of diabetes mellitus in Spain as results of the nation-wide cohort di@bet.es studyHigh levels of fasting glucose and glycosylated hemoglobin values are associated with hyperfiltration in a Spanish prediabetes cohort. The PREDAPS StudyGlycaemic control after treatment intensification in patients with type 2 diabetes uncontrolled on two or more non-insulin antidiabetic drugs in a real-world setting
P50
Q34307460-0AFC32DF-D8EC-4D00-B7E9-C78FFF04434AQ34385492-4F1D2247-3762-41BF-804F-467024FF383AQ35805646-B5DDC0A1-6A13-4138-84DE-DC1C610CC30DQ35841178-E91B0E7A-908F-4ACB-AAA3-49A34B6A18C6Q35926064-0DB12389-A16F-4D24-ACD0-510EBE7B2581Q36156101-AD26806A-0731-406F-958C-1AC37D31B612Q36374753-D77FB948-F285-4868-AA3B-6C4E18C7DF13Q36531654-E364383B-5D2C-4AE8-B904-367F98CAE61CQ36645367-38B1C38B-8A61-4EC0-A2F0-F9D39D683F2FQ36969176-F50FAD0B-844B-4666-9B29-42895B7FC148Q37026196-128009C8-A78F-4809-B2DA-F874F531117AQ37306507-9C643C91-4BDB-47CC-A2FE-6E4CF60AB587Q37320310-F8F7DE7F-A388-457B-9691-3A93E3B44AF2Q37413097-8AF39F30-78E8-47AD-AE57-3CE3508E639FQ38918802-265F5678-24CD-4457-9859-F945BAFA38DEQ38950536-8C74BED1-D284-45DE-B2D5-9797476D6D3DQ39757520-AA01EE9E-85E6-450E-B428-402332371ACEQ43274399-99C84C95-AC70-40AD-A39A-6994D642B4A8Q44097108-FAB7490C-A4ED-46AC-8291-01089FB04A4CQ45389348-41E7FA18-1DBD-42BD-ACF1-21F47F8C5C7CQ47780799-007F1BE6-7818-427E-9154-4046125FD678Q47879625-2C71062E-8213-41EB-A755-663FFDD64495Q50271509-FF23B71F-6436-4C22-BEC7-A2F306F7B761Q50458568-C91D0FA4-E347-48E6-A502-351CFBD6278CQ50729287-0AABCBE0-23FA-4F23-9887-EC8BF1365E8CQ54792988-CDA9ADA2-8D05-4A72-9619-D01CB01B1749Q57470663-B68139EA-A151-4E92-BCCA-4BC0562133CBQ57524038-58CEA164-C1A9-436E-8F57-E236FE2B3B26Q61890387-F8C5C59E-7162-4115-B5A5-CE5C1A741980Q61890394-4975488F-F19C-4CEA-8F07-F150F1792B5FQ61890410-F298B299-ED97-41EF-9686-B9DA1AF2368DQ61890414-57991D2B-6A8E-4F54-BC89-B4DBB4A774D1Q61890417-549A06A4-3309-4F6D-AF5F-6BF130F51F41Q61890422-20D7FE39-3EDA-4A8D-BCDA-73B2522A3904Q64256195-8D7EE491-7B96-4361-997F-158E00E2B70DQ64910903-D1396330-49BE-4137-ADE2-97B35B1F7EA0Q89582068-B2A263B7-189E-4AE6-9BDC-67692EFF7F75Q89748084-C270F4E8-11F5-4326-8B62-9D5CAD558C55Q90178919-6D9B17F9-782D-49C4-BFAE-A1684C3676B0Q91526197-55DAAEBC-34F1-4862-961A-25056859F2EF
P50
description
Spaans onderzoeker
@nl
hulumtues
@sq
researcher
@en
ricercatore
@it
taighdeoir
@ga
հետազոտող
@hy
name
Josep Franch-Nadal
@ast
Josep Franch-Nadal
@en
Josep Franch-Nadal
@es
Josep Franch-Nadal
@ga
Josep Franch-Nadal
@nl
Josep Franch-Nadal
@sl
type
label
Josep Franch-Nadal
@ast
Josep Franch-Nadal
@en
Josep Franch-Nadal
@es
Josep Franch-Nadal
@ga
Josep Franch-Nadal
@nl
Josep Franch-Nadal
@sl
prefLabel
Josep Franch-Nadal
@ast
Josep Franch-Nadal
@en
Josep Franch-Nadal
@es
Josep Franch-Nadal
@ga
Josep Franch-Nadal
@nl
Josep Franch-Nadal
@sl
P106
P1153
6701653693
P21
P214
7145424145986791537
P27
P31
P3835
josep-franch2
P496
0000-0002-5175-1555